Top Marijuana Shares in the NASDAQ

Top Marijuana Shares in the NASDAQ

Even though greater part of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a few cannabis organizations are exchanged in the NASDAQ. Some investors choose shares which can be noted on the NASDAQ to many other exchanges because of their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. For instance, because the cannabis industry has exploded in present months and years, uplisting from an OTC market to a professional U.S. change happens to be an advertising achievement for several increasing cannabis companies. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An increasing quantity of marijuana companies are now being noted on reputable U.S. exchanges in the place of being traded regarding the OTC market reflecting the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ had been the initial electronic trade and is certainly synonymous with technology and biotechnology. The cannabis businesses on the NASDAQ mirror this, additionally the majority of them run within the biotech area of this industry. Here you will find the NASDAQ-listed marijuana shares, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is just a biotech business active in the production of medical cannabis medications. Research and development around Arena’s APD371 could be the main focus associated with the company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a blank check business that is currently in a merger contract with Kalyx developing Inc. Kalyx is a prominent investment rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, especially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis will be found in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic diseases.
  • Organizations will also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new for the indications of pain and pruritus (itching). Although every one of the company’s clinical-stage items target opioid receptors, Cara is performing research that is preclinical cannabinoids for the treating neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to take care of chronic, inflammatory, fibrotic, as well as other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a cannabis that are canadian. The group owns and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with additional money to finance its continued expansion but in addition by having a partner that is well-established within the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis consumption accessories and vaporization equipment and items to customers that are retail the U.S. and Canada. Also, it runs websites that are e-commerce extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is developing a profile of cannabinoid medicines. These medications consist of Sativex for the treating spasticity associated with sclerosis that is multiple cancer tumors pain and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations outside of the united states of america and has now gotten regulatory approval in various other nations. Epidiolex received FDA approval as a therapy plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, very very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid services and products for autism range disorders, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing medications centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based drugs for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal for use on cannabis plants within the Ca cultivation market.

New Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is really a maker of beverages derived from yerba mate, green tea, kombucha, and comparable services and products. In present months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted in the NASDAQ in might of 2019, which makes it the most present cannabis companies to record in the popular change. The business is quickly expanding its manufacturing ability and might manage to create up to 113,000 kilograms of item per by the end of 2019 year.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates within the enforcement sector. The company’s business operations support medication screening through hair samples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another new entry on the NASDAQ exchange. The cannabis producer made headlines in October of 2019 (and saw a quick cost boost) whenever it announced the release of an innovative new Palmetto make of leisure cannabis, first available in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage company that is pharmaceutical from the growth of cannabinoid-based medications. Therapix’s current pipeline includes items targeted to treat Tourette problem and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. had been the initial marijuana-related business to have a preliminary general general public offering (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis items.

Village Farms International (NASDAQ:VFF)

Village Farms Global is considered the most current cannabis stock to begin dealing from the NASDAQ. The business’s shares became designed for trade on 21, 2019 february. The organization features a history that is decades-long greenhouse produce manufacturing and has now only recently shifted a few of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted in the growth of synthetic cannabinoid remedies for transdermal (through your skin) delivery. Their pipeline presently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and Fragile X syndrome.

Like or Share Us: